Inhibitory effects of resveratrol and pterostilbene on human colon cancer cells: A side-by-side comparison

78Citations
Citations of this article
60Readers
Mendeley users who have this article in their library.
Get full text

Abstract

The effects of resveratrol and pterostilbene (two structurally related stilbene compounds) on three human colon cancer cells were systematically compared. Cell viability tests indicated that IC 50 values of pterostilbene were 2-5-fold lower than those of resveratrol in all three cancer cells. Pterostilbene was also more potent in inhibiting colony formation of all three cancer cells. Annexin V/propidium iodide costaining assay and Western blotting analysis showed pterostilbene had a stronger apoptosis-inducing effect, which was evidenced by the higher percentage of annexin V positive cells and higher levels of cleaved caspase-3 and poly(ADP-ribose) polymerase proteins in cancer cells treated with pterostilbene compared with resveratrol. High-performance liquid chromatography analysis demonstrated that intracellular levels of pterostilbene were 2-4-fold higher than those of resveratrol after treatments with individual compounds at the same concentration. Overall, the results demonstrated that pterostilbene had more potent inhibitory effects on colon cancer cells than resveratrol, which may be associated with the superior bioavailability of pterostilbene to resveratrol. © 2011 American Chemical Society.

Cite

CITATION STYLE

APA

Nutakul, W., Sobers, H. S., Qiu, P., Dong, P., Decker, E. A., McClements, D. J., & Xiao, H. (2011). Inhibitory effects of resveratrol and pterostilbene on human colon cancer cells: A side-by-side comparison. Journal of Agricultural and Food Chemistry, 59(20), 10964–10970. https://doi.org/10.1021/jf202846b

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free